In 2026, IT departments will experience major changes compared to recent years. Digitalization is no longer optional, and companies that fail to evolve their IT services will be exposed to cyberattacks, operational disruptions, and a loss of competitiveness.

When people talk about an “industrial SOC,” many small and medium-sized enterprises (SMEs) in the agri-food sector see it as an investment beyond their reach: they picture rooms full of analysts, high fixed costs, and technology that only large corporations can understand. That perception isn’t entirely unfounded, but it doesn’t reflect the current reality of the market or the alternatives that now exist.

In the retail sector, where customer experience and operational continuity are critical, cybersecurity has become a strategic priority. The increasing digitalization and expansion of operations into distributed environments have enlarged the attack surface, making it necessary to deploy advanced solutions such as EDR (Endpoint Detection and Response) and XDR (Extended Detection and Response).

The convergence of advanced artificial intelligence and biomedical data has opened up a wide range of revolutionary possibilities in medicine and research. However, it has also introduced emerging risks that demand immediate attention from a cybersecurity perspective. Among these risks, the use of Deepfake technologies and the manipulation of biomedical data represent a growing threat, with critical implications for information integrity, trust in healthcare systems, and patient safety.

Logistics is the engine that keeps the global economy running.

Food traceability has become one of the most important pillars for ensuring food safety, regulatory compliance, and consumer trust. However, with the digitization of the supply chain and the adoption of technologies such as blockchain, IoT, and ERP systems, new vulnerabilities also emerge that can be exploited by cybercriminals.

In the retail sector, digital security has become a critical element in ensuring customer trust and operational continuity. Physical stores and e-commerce platforms constantly face the risk of cyberattacks that can compromise sensitive information, disrupt operations, and damage brand reputation. In this context,Threat Hunting in retail emerges as an essential strategy to detect and anticipate attacks before they cause harm.

The biotechnology and medical sector has undergone a significant transformation with the integration of advanced digital technologies. Laboratory equipment, diagnostic devices, and monitoring systems are now network-connected, equipped with sophisticated firmware, and managed through digital interfaces. While this digitalization enhances the efficiency and capabilities of these devices, it also introduces new attack surfaces for cybercriminals.

Zero Trust is a security model based on the principle that no entity, whether inside or outside the corporate network—should be automatically trusted. This approach involves continuously verifying the identity, context, and security posture of all devices and users before granting access to critical resources.

The digitalization of the retail sector has been key to improving customer experience and optimizing operational processes. However, this transformation has also exposed companies in the sector to a growing wave of cyberattacks. From e-commerce platforms to point-of-sale (POS) terminals, attack surfaces have multiplied, along with the risks to data integrity and business continuity.

The biotech sector is revolutionizing health, agriculture, and science with innovations that can change the world. But with great advancements come great risks, especially when it comes to cybersecurity. Critical information from clinical trials, intellectual property, and sensitive patient data has become the perfect target for cybercriminals and their cyberattacks.

The biotechnology sector has been one of the fastest-growing industries in recent years, known for its innovation in drug development, diagnostics, and advanced therapies. However, this progress has also attracted the attention of cybercriminals. In 2023, ransomware became one of the main threats to biotechs, jeopardizing the security of critical data and operational continuity.